Navigation Links
Lilly Announces Changes in Key Leadership Roles
Date:5/21/2008

m the company, which has also led to changes in the management structure.

Tim Franson, M.D., vice president of global regulatory affairs, will retire from the company after 22 years of service. Franson is a diplomat of the American Board of Internal Medicine, a Fellow of the American College of Physicians and the Infectious Diseases Society of America, and played a leadership role on behalf of both Lilly and the industry in the reshaping of the Prescription Drug User Fee Act. He has held roles of increasing responsibility throughout his career at Lilly, including positions in medical (both in the U.S. and in Europe), health economics research and decision sciences, clinical research, and regulatory affairs. He has held his current position since 2003.

Alan Breier, M.D., vice president of medical and chief medical officer, has been appointed full professor in the department of psychiatry at the Indiana University School of Medicine after an 11-year career at Lilly. Breier, who joined Lilly in 1997 from the National Institutes of Health (NIH), has published more than 235 scientific articles in areas related to the cause and treatment of severe mental illnesses, and last year was honored by the American Psychiatric Association for excellence in medical student education. Breier has held a variety of leadership roles at Lilly on the Zyprexa(R) product team as well as in medical, and has served as the chief medical officer since 2003.

"Both Tim and Alan have provided exceptional leadership on behalf of our company and wise counsel to me personally. Their contributions to our organization and to the patients we serve have been very significant, and they will both be missed. Our deepest thanks and best wishes go with both of them as they embark on new endeavors," said Steve Paul, M.D., executive vice president of science and technology and president of LRL.

The primary change to the LRL structure is the creation of a combined global regulatory,
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
2. Robert J. Heine, M.D., Ph.D., F.R.C.P. to Join Lilly; Distinguished Diabetes Expert to Lead Diabetes/Endocrine Medical Division
3. Lauren Marangell, M.D. to Join Lilly; Internationally Recognized Expert in Depression Joins as Distinguished Lilly Scholar
4. Genentech/Roches Lucentis and Eli Lillys Ruboxistaurin Will Drive the Diabetic Retinopathy and Nephropathy Drug Markets
5. Lillys CEO Calls for Reform of Nations Drug Safety System
6. Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels
7. Lilly Grant to VA Will Enhance Services for Returning Combat Veterans
8. Lilly Delivers Strong Third-Quarter Results
9. Lilly and MacroGenics Announce Licensing and Collaboration Agreement
10. Eli Lilly and Company Aids California Recovery Effort
11. Eli Lilly and Company Announces 2007 Lilly Reintegration Awards Recipients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... Dennis Thompson HealthDay Reporter ... early or at low birth weight are at risk later ... problems that increase their risk for heart disease, according to ... children face potential lifetime disadvantages, researchers in both studies ... found that these obstacles can be overcome. Education appeared ...
(Date:9/2/2014)... Dallas, Texas (PRWEB) September 02, 2014 ... , “North America Resectoscopes Market Outlook to 2020? ... Resectoscopes market. The report provides value, in millions ... prices (in US dollars) within market segments –, ... Electrodes (Monopolar (Disposable and Reusable) Electrodes and Bipolar ...
(Date:9/2/2014)... Lancet is pleased to announce that the ... presentation at the ESC Congress 2014, taking place ... 2014: , Ultrathin strut biodegradable polymer sirolimus-eluting ... coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial, ... design affecting strut thickness, surface polymer, and drug ...
(Date:9/2/2014)... 02, 2014 Eric Jimenez and Leah ... , a revolutionary makeup application device. Designed to improve ... innovation in the palm of women’s hands to help ... to Color Me’s success lies in its patented technology. ... rate of 15,000 pulses per minute, the device applies ...
(Date:9/2/2014)... 02, 2014 With thoughts of getting ... the minds of many Washingtonians, it’s easy to forget ... and office managers to be booking their organizations’ holiday ... Resorts' Washington, DC, area locations are preparing for the ... available for holiday parties, the space appears to be ...
Breaking Medicine News(10 mins):Health News:Preterm or Small Birth Tied to Long-Term Risks to Heart, Brain 2Health News:Preterm or Small Birth Tied to Long-Term Risks to Heart, Brain 3Health News:North America Resectoscopes & Bronchoscopes Market (Revenue, Volume & Company Share) to 2020 Report Available at MarketOptimizer.org 2Health News:North America Resectoscopes & Bronchoscopes Market (Revenue, Volume & Company Share) to 2020 Report Available at MarketOptimizer.org 3Health News:North America Resectoscopes & Bronchoscopes Market (Revenue, Volume & Company Share) to 2020 Report Available at MarketOptimizer.org 4Health News:The Lancet: European Society of Cardiology Congress 2014 media alert 2Health News:Color Me Launches With Ulta Beauty Revolutionary Makeup Application Device Gets Women Flawless in a Flash 2Health News:Color Me Launches With Ulta Beauty Revolutionary Makeup Application Device Gets Women Flawless in a Flash 3Health News:Fall in Washington, DC, Is When a Meeting Planner’s Mind Turns to … the Winter Holidays? 2Health News:Fall in Washington, DC, Is When a Meeting Planner’s Mind Turns to … the Winter Holidays? 3Health News:Fall in Washington, DC, Is When a Meeting Planner’s Mind Turns to … the Winter Holidays? 4Health News:Fall in Washington, DC, Is When a Meeting Planner’s Mind Turns to … the Winter Holidays? 5
... the number of global users outnumbering other users of ... authorities from the U.S have warned that if appropriate ... could lead to a global threat. ,Methamphetamine ... a stimulant that induces euphoria in its users. Discovered ...
... who had been bitten by a bat and subsequently diagnosed with ... observation. Although treatment is being offered, the chances of the boy ... boy, a student of Humble High School fell ill last week, ... weeks before this could happen, a bat had flown into his ...
... a novel study conducted at the University of Illinois at ... happened after the victim was drugged// and in 5% of ... 100,000 sexual assaults are committed in the United States each ... times higher if all cases were reported, said Adam Negrusz, ...
... Queeen's has suggested that patients who combine a low ... better results in clearing toxins and increasing overall physical ... of dialysis patients was recently carried out by Rehabilitation ... and Respiratory (CCR) group at Queen's, and a group ...
... conducted a joint cell and animal study that has revealed ... malaria, often causing death. ,The culprit is a protein ... to suppress red blood cell production in people whose red ... ,The parasite that causes malaria - known as plasmodium - ...
... million American adults are smokers, obese or both and are faced ... // ,Data from a 2002 national health interview ... United States who have one or both problems. ,The ... million people and this would include a larger percentage of them ...
Cached Medicine News:Health News:Meth Addiction On The Rise, US Health Authorities Concerned 2Health News:UIC Study Throws Light On Sexual Assaults 2Health News:Exercise Combined with Dialysis Yields Better Results 2Health News:Anemia from Malaria Linked to a Protein MIF 2Health News:Anemia from Malaria Linked to a Protein MIF 3
(Date:9/2/2014)... , Sept. 2, 2014  Amgen ... the submission of a Marketing Authorization Application ... via the centralized procedure for talimogene laherparepvec ... with melanoma that is regionally or distantly ... administered as an intralesional injection that is ...
(Date:9/2/2014)... FRANCISCO, Calif. , Sept. 2, 2014   Veracyte, ... Bonnie H. Anderson , president and chief executive officer, ... Morgan Stanley Global Healthcare Unplugged Conference 2014 on Monday, September ... York . The live audio webcast and ... http://investor.veracyte.com . Please connect to the website at least ...
(Date:9/2/2014)... Redspin, Inc., a leading provider of HIPAA ... an IT security advisory specifically for senior executives in ... presiding over the most dynamic period in the history ... Redspin,s President and CEO. "The goal of our advisory ... understand why they need to elevate IT security to ...
Breaking Medicine Technology:Amgen Submits Marketing Authorization Application For Talimogene Laherparepvec To The European Medicines Agency 2Amgen Submits Marketing Authorization Application For Talimogene Laherparepvec To The European Medicines Agency 3Amgen Submits Marketing Authorization Application For Talimogene Laherparepvec To The European Medicines Agency 4Amgen Submits Marketing Authorization Application For Talimogene Laherparepvec To The European Medicines Agency 5Amgen Submits Marketing Authorization Application For Talimogene Laherparepvec To The European Medicines Agency 6Veracyte to Present at the Morgan Stanley Global Healthcare Unplugged Conference 2014 2
... importance of dedicated information management systems for radiation ... most recent version of its MOSAIQ® Oncology Information ... Systems Society,s 2012 conference (HIMSS12), Feb. 20-24, in ... comprehensive OIS that centralizes traditional radiation oncology, particle ...
... Feb. 16, 2012  Cardium Therapeutics (NYSE Amex: ... previously announced sale of 17,857,143 shares of its common ... of approximately $5.0 million, before deducting placement agent,s fees ... investors participating in the offering purchased the shares at ...
Cached Medicine Technology:Elekta Highlights Latest Version of MOSAIQ Oncology Information System at HIMSS12 Meeting 2Cardium Announces Closing of $5.0 Million Equity Financing 2Cardium Announces Closing of $5.0 Million Equity Financing 3
...
The Tew cranial/spinal retractor is designed for posterior fossa or intraspinal microsurgery where retraction is required. Clinical applications are: Posterior fossa microsurgery and intraspinal micr...
The Doro Halo retractor system is designed for all neurosurgical applications where retraction of the brain tissue and an armrest is required....
The Budde Halo brain retractor is designed for use in all intercranial procedures where retraction of delicate brain tissue is required....
Medicine Products: